ClinicalTrials.Veeva

Menu

Detection of Anemizations in Primary Care. (ANHEMOG)

F

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Status

Unknown

Conditions

Anemia
Red Blood Cell Transfusion

Treatments

Diagnostic Test: Monthly Haemoglobinometry

Study type

Interventional

Funder types

Other

Identifiers

NCT04757909
4R18/08 (Other Grant/Funding Number)
4R17/013 (Other Grant/Funding Number)

Details and patient eligibility

About

Objective: To evaluate the effect of the use of the hemoglobinometer in primary care on the clinical results of patients with chronic anemia.

Methods: The ANHEMOG study is a randomized controlled trial with two parallel arms, intervention and control. It was approved at december 11, 2017. The study randomizes 138 patients with chronic anemia. In the intervention arm, a monthly capillary hemoglobin measurement will be performed with a hemoglobinometer. If a decrease in hemoglobin concentration is detected, an existing transfusion circuit will be followed. Social, demographic and quality of life variables will be collected from all participants.

Hypothesis:

The results of the research will have an impact on people with chronic anemia who would receive red blood cell transfusion when needed without delay. The improvement in the times of action would reduce decompensations from chronic diseases, visits to the emergency room and hospital admissions, and therefore would improve the quality of life of these patients. Furthermore, the management of the different interventions by the Case Management Nurse (EGC), in this regard, improves the current fragmentation of the different levels of care.

Enrollment

33 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People over 40 years old
  • Had received 2 or more red blood cell transfusions due to chronic disease, during a year.
  • The health provider in Primary Care is the Institut Català de la Salut.

Exclusion criteria

  • Presenting kidney failure on hemodialysis treatment.
  • Being in palliative care situation
  • Presenting a moderate-severe cognitive impairment, with a Pfeiffer scale score higher than 5.
  • Not having a caregiver able to detect signs of decompensation.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

33 participants in 2 patient groups

Monthly Haemoglobinometry
Experimental group
Treatment:
Diagnostic Test: Monthly Haemoglobinometry
Routine monitoring
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Boris Trenado Luengo, RN; Pere Toran-Montserrat, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems